Logo image of ABVE

ABOVE FOOD INGREDIENTS INC (ABVE) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ABVE - CA00373V1004 - Common Stock

2.26 USD
-0.07 (-3%)
Last: 1/9/2026, 8:00:00 PM
2.29 USD
+0.03 (+1.33%)
After Hours: 1/9/2026, 8:00:00 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ABVE. ABVE was compared to 87 industry peers in the Food Products industry. Both the profitability and financial health of ABVE have multiple concerns. ABVE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ABVE has reported negative net income.
ABVE had a positive operating cash flow in the past year.
ABVE had negative earnings in each of the past 5 years.
In the past 5 years ABVE reported 4 times negative operating cash flow.
ABVE Yearly Net Income VS EBIT VS OCF VS FCFABVE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -20M -40M

1.2 Ratios

The Return On Assets of ABVE (-107.17%) is worse than 90.80% of its industry peers.
Industry RankSector Rank
ROA -107.17%
ROE N/A
ROIC N/A
ROA(3y)-21.86%
ROA(5y)-13.11%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ABVE Yearly ROA, ROE, ROICABVE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

1.3 Margins

ABVE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ABVE Yearly Profit, Operating, Gross MarginsABVE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -5 -10

More info and screens

1

2. Health

2.1 Basic Checks

ABVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
ABVE has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for ABVE is higher compared to a year ago.
ABVE Yearly Shares OutstandingABVE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ABVE Yearly Total Debt VS Total AssetsABVE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of 1.31, we must say that ABVE is in the distress zone and has some risk of bankruptcy.
ABVE has a worse Altman-Z score (1.31) than 66.67% of its industry peers.
ABVE has a debt to FCF ratio of 21.93. This is a negative value and a sign of low solvency as ABVE would need 21.93 years to pay back of all of its debts.
ABVE has a Debt to FCF ratio (21.93) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 21.93
Altman-Z 1.31
ROIC/WACCN/A
WACC6.94%
ABVE Yearly LT Debt VS Equity VS FCFABVE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 20M -20M -40M

2.3 Liquidity

ABVE has a Current Ratio of 0.23. This is a bad value and indicates that ABVE is not financially healthy enough and could expect problems in meeting its short term obligations.
ABVE has a worse Current ratio (0.23) than 94.25% of its industry peers.
ABVE has a Quick Ratio of 0.23. This is a bad value and indicates that ABVE is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.18, ABVE is doing worse than 94.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.18
ABVE Yearly Current Assets VS Current LiabilitesABVE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for ABVE have decreased strongly by -145.55% in the last year.
Looking at the last year, ABVE shows a very strong growth in Revenue. The Revenue has grown by 84.68%.
EPS 1Y (TTM)-145.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2053%
Revenue 1Y (TTM)84.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ABVE Yearly Revenue VS EstimatesABVE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 100M 200M 300M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ABVE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ABVE Price Earnings VS Forward Price EarningsABVE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

ABVE's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 37.63
EV/EBITDA N/A
ABVE Per share dataABVE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ABVE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

ABOVE FOOD INGREDIENTS INC

NASDAQ:ABVE (1/9/2026, 8:00:00 PM)

After market: 2.29 +0.03 (+1.33%)

2.26

-0.07 (-3%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)11-18 2024-11-18
Earnings (Next)N/A N/A
Inst Owners12.92%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap115.69M
Revenue(TTM)732.19M
Net Income(TTM)-120.40M
AnalystsN/A
Price TargetN/A
Short Float %2.41%
Short Ratio0.43
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.22
P/FCF 37.63
P/OCF 19.32
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.06
FCFY2.66%
OCF(TTM)0.12
OCFY5.18%
SpS10.3
BVpS-1.62
TBVpS-1.67
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -107.17%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 0.58%
ROA(3y)-21.86%
ROA(5y)-13.11%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover6.52
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 21.93
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.23
Quick Ratio 0.18
Altman-Z 1.31
F-Score4
WACC6.94%
ROIC/WACCN/A
Cap/Depr(3y)596.86%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.21%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-145.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2053%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)84.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-145.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y715.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1299.37%
OCF growth 3YN/A
OCF growth 5YN/A

ABOVE FOOD INGREDIENTS INC / ABVE FAQ

What is the fundamental rating for ABVE stock?

ChartMill assigns a fundamental rating of 1 / 10 to ABVE.


What is the valuation status for ABVE stock?

ChartMill assigns a valuation rating of 1 / 10 to ABOVE FOOD INGREDIENTS INC (ABVE). This can be considered as Overvalued.


What is the profitability of ABVE stock?

ABOVE FOOD INGREDIENTS INC (ABVE) has a profitability rating of 0 / 10.


How financially healthy is ABOVE FOOD INGREDIENTS INC?

The financial health rating of ABOVE FOOD INGREDIENTS INC (ABVE) is 1 / 10.